Stay updated on Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial page.

Latest updates to the Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial page
- Check2 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest has been deleted.SummaryDifference0.7%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.6%
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1.0%
- Check67 days agoChange DetectedThe web page has been updated to include new results and assessments related to the Combined Assessment of Function and Survival (CAFS) and treatment-emergent adverse events (TEAEs) for a study on ALS, while previous data regarding the same metrics has been removed.SummaryDifference91%
- Check81 days agoChange DetectedThe page has been updated to include the term 'Amyotrophic Lateral Sclerosis' and the new revision number 'v2.15.0', while significant details about a Phase 2 study and its criteria have been removed.SummaryDifference15%
Stay in the know with updates to Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial page.